Steven Dubinett, MD
Associate Vice Chancellor for Research, UCLA
Senior Associate Dean, Translational Research, David Geffen School of Medicine at UCLA
Professor, Medicine, Molecular & Medical Pharmacology, Institute for Molecular Medicine
Director, Clinical and Translational Science Institute, CTSI
Chief, Pulmonary and Critical Care Medicine
Division Chief, Clinical Immunology and Allergy
David Geffen School of Medicine at the University of California, Los Angeles
Steven M. Dubinett, MD, is Associate Vice Chancellor for Research at UCLA and Senior Associate Dean for Translational Research at the David Geffen School of Medicine. He is Chief of the Division of Pulmonary and Critical Care Medicine and jointly appointed as Professor in the Departments of Medicine, Pathology and Laboratory Medicine, and Molecular and Medical Pharmacology.
Dr. Dubinett has experience in translational investigation, academic administration, mentorship and peer review. He has served on national advisory panels and committees including the NCI’s Translational Research Working Group and chairs the FDA Advisory Committee for Cellular, Tissue and Gene Therapies. He has directed multidisciplinary research teams funded by the NCI SPORE program, the Early Detection Research Network and the Department of Defense. He has served as a member of three NIH study sections and numerous Special Emphasis Panels. Dr. Dubinett has been funded by peer-reviewed federal agencies for translational research in lung cancer for more than 20 years. His translational studies focus on the microenvironment, inflammation and epithelial mesenchymal transition in the pathogenesis of lung cancer. He is Associate Editor in Chief of the American Journal of Translational Research and serves on several editorial boards, including Clinical and Translational Science.
Dr. Dubinett's research interests include inflammation dependent regulation of tumor development and progression in lung cancer and lung cancer chemoprevention and early detection. Dr. Dubinett attained his medical degree from the New Jersey Medical School and completed his clinical and research training at the Massachusetts General Hospital, Harvard University and the University of California, Los Angeles.